CHOP Investigator and Experimental One-dose Gene Therapy for Hemophilia B Featured in The New York Times
Aug 13, 2018
CHOP breakthrough helps scientists edge closer to defeating a longtime enemy of human health: hemophilia, the inability to form blood clots.